These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15898742)
41. Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes. Chen KC; Cheng TL; Leu YL; Prijovich ZM; Chuang CH; Chen BM; Roffler SR Cancer Gene Ther; 2007 Feb; 14(2):187-200. PubMed ID: 16977328 [TBL] [Abstract][Full Text] [Related]
42. Phosphoramidate and phosphate prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine: synthesis, anti-HIV activity and stability studies. Liang Y; Narayanasamy J; Schinazi RF; Chu CK Bioorg Med Chem; 2006 Apr; 14(7):2178-89. PubMed ID: 16314108 [TBL] [Abstract][Full Text] [Related]
43. Determination of the specificity of monoclonal antibodies against Schistosoma mansoni CAA glycoprotein antigen using neoglycoconjugate variants. Carvalho de Souza A; van Remoortere A; Hokke CH; Deelder AM; Vliegenthart JF; Kamerling JP Biol Chem; 2005 Sep; 386(9):901-8. PubMed ID: 16164415 [TBL] [Abstract][Full Text] [Related]
44. A doxorubicin prodrug activated by the staudinger reaction. van Brakel R; Vulders RC; Bokdam RJ; Grüll H; Robillard MS Bioconjug Chem; 2008 Mar; 19(3):714-8. PubMed ID: 18271515 [TBL] [Abstract][Full Text] [Related]
45. Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature. Shin IS; Jang BS; Danthi SN; Xie J; Yu S; Le N; Maeng JS; Hwang IS; Li KC; Carrasquillo JA; Paik CH Bioconjug Chem; 2007; 18(3):821-8. PubMed ID: 17375899 [TBL] [Abstract][Full Text] [Related]
46. Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry. Gopin A; Ebner S; Attali B; Shabat D Bioconjug Chem; 2006; 17(6):1432-40. PubMed ID: 17105221 [TBL] [Abstract][Full Text] [Related]
47. Immunologically specific activation of a cephalosporin derivative of mitomycin C by monoclonal antibody beta-lactamase conjugates. Vrudhula VM; Svensson HP; Senter PD J Med Chem; 1997 Aug; 40(17):2788-92. PubMed ID: 9276025 [TBL] [Abstract][Full Text] [Related]
48. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity. Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379 [TBL] [Abstract][Full Text] [Related]
49. A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer. Haisma HJ; Boven E; van Muijen M; de Jong J; van der Vijgh WJ; Pinedo HM Br J Cancer; 1992 Sep; 66(3):474-8. PubMed ID: 1520585 [TBL] [Abstract][Full Text] [Related]
51. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Kratz F J Control Release; 2008 Dec; 132(3):171-83. PubMed ID: 18582981 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression. Chang YT; Cheng CM; Su YZ; Lee WT; Hsu JS; Liu GC; Cheng TL; Wang YM Bioconjug Chem; 2007; 18(6):1716-27. PubMed ID: 17935289 [TBL] [Abstract][Full Text] [Related]
53. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents. Mishra S; Karmodiya K; Parasuraman P; Surolia A; Surolia N Bioorg Med Chem; 2008 May; 16(10):5536-46. PubMed ID: 18434169 [TBL] [Abstract][Full Text] [Related]
54. Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence. Wehrman TS; von Degenfeld G; Krutzik PO; Nolan GP; Blau HM Nat Methods; 2006 Apr; 3(4):295-301. PubMed ID: 16554835 [TBL] [Abstract][Full Text] [Related]
55. Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy. Fang L; Sun D Drug Metab Dispos; 2008 Jun; 36(6):1153-65. PubMed ID: 18356268 [TBL] [Abstract][Full Text] [Related]
56. Enzymatic synthesis of N-acetyllactosamine in aqueous-organic reaction media. Franke J; Braun K; Kuhl P Pharmazie; 2003 Dec; 58(12):857-9. PubMed ID: 14703960 [TBL] [Abstract][Full Text] [Related]
57. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes. Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877 [TBL] [Abstract][Full Text] [Related]
58. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933 [TBL] [Abstract][Full Text] [Related]
60. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity. Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]